<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="32073" end="32078" sStart="-1" offset="0" sid="null" wn="2" wnkey="write%2:32:00::" text="The author (1) JRA developed and &lt;b&gt;wrote&lt;/b&gt; this report." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="31678" end="31683" sStart="null" offset="109" sid="r7.1.use.v.0438" wn="1" wnkey="use%2:34:01::" text="Inclusion of more diverse and non-clinical populations of obese and extremely obese individuals, and using research designs that better account for rater and subject biases, inter-rater reliability, and diagnostic methodology, will likely give more definitive answers to this report's questions and implications." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="27417" end="27427" sStart="null" offset="52" sid="r8.suggest.v.0739" wn="3" wnkey="suggest%2:32:02::" text="At this point, it remains an open question, suggesting additional reasons for cautious interpretation of the results given in this report." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="3802" end="3809" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="Fortunately, ADHD patients often responded to pharmacological and behavior therapies, with results that included improved task persistence, decreased impulsivity and distractability, and for some, greater &lt;b&gt;success&lt;/b&gt; with weight control efforts." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="3802" end="3809" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="Fortunately, ADHD patients often responded to pharmacological and behavior therapies, with results that included improved task persistence, decreased impulsivity and distractability, and for some, greater &lt;b&gt;success&lt;/b&gt; with weight control efforts." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="11731" end="11737" sStart="null" offset="146" sid="r11.severe.j.0369" wn="5" wnkey="severe%5:00:00:critical:03" text="Subjects were characterized by a variable level of obesity, divided into one of three obesity classes (overweight:Ov, moderate to severe obesity:I-II, and extreme obesity:III), and a range of symptoms (AD, ADSx, or NAD)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="15687" end="15693" sStart="null" offset="4" sid="r8.number.n.0215" wn="1" wnkey="number%1:07:00::" text="The number of months in treatment was not significantly different among the patient groups (F = 2.03, df = 2,212, p = 0.13), though there appeared to be a trend toward alonger duration of treatment in AD." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="3270" end="3274" sStart="null" offset="0" sid="null" wn="1" wnkey="lose%2:40:02::" text="In the bariatric clinic at Behavioral Medicine Center for Treatment and Research (BMedCTR) in Portland, Oregon, among the patients who failed, a subset was observed to have unusual difficulty adhering to diet and exercise plans, and as a result &lt;b&gt;lost&lt;/b&gt; less fat mass than typically occurs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="10286" end="10291" sStart="null" offset="29" sid="r9.level.n.0532" wn="2" wnkey="level%1:26:01::" text="None of the ADHD group had a level of hyperactivity-impulsivity meeting DSM-IV criteria, therefore all were classifiable as having Inattentive Type of ADHD." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-244X-2-9.anc" start="20509" end="20514" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="In other studies, administration of D2 agonists resulted in decreases in hyperinsulinemia associated with obesity [ 36 ] , and it is &lt;b&gt;known&lt;/b&gt; that the brain is richly supplied with insulin receptors, including the cortex and striatal areas [ 37 ] , suggesting an intriguing link between insulin resistance, characteristic of obesity, and dopamine-mediated psychiatric symptoms, including ADHD." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-244X-2-9.anc" start="20509" end="20514" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="In other studies, administration of D2 agonists resulted in decreases in hyperinsulinemia associated with obesity [ 36 ] , and it is &lt;b&gt;known&lt;/b&gt; that the brain is richly supplied with insulin receptors, including the cortex and striatal areas [ 37 ] , suggesting an intriguing link between insulin resistance, characteristic of obesity, and dopamine-mediated psychiatric symptoms, including ADHD." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="20197" end="20205" sStart="null" offset="93" sid="r11.function.n.0863" wn="4" wnkey="function%1:24:01::" text="A recent study showed the availability of striatal DRD2 receptors was decreased as a function of increasing BMI [ 35 ] , supporting the idea that reward-seeking behavior plays a role in the onset or continuation of obesity." />
    <s path="file:/C:/OANC/data/written_2/technical/biomed/1471-244X-2-9.anc" start="26442" end="26450" sStart="null" offset="0" sid="null" wn="4" wnkey="exercise%2:29:00::" text="For the OB+ADHD population, the idea is that some patients may have had a preference for endorsing ADHD symptoms, instead of accepting more accurate explanations for distress or lack of obesity treatment progress, e.g., failure to lose weight while being unwilling to &lt;b&gt;exercise&lt;/b&gt;." />
    <s path="file:/C:/OANC/data/written_2/technical/biomed/1471-244X-2-9.anc" start="26442" end="26450" sStart="null" offset="0" sid="null" wn="4" wnkey="exercise%2:29:00::" text="For the OB+ADHD population, the idea is that some patients may have had a preference for endorsing ADHD symptoms, instead of accepting more accurate explanations for distress or lack of obesity treatment progress, e.g., failure to lose weight while being unwilling to &lt;b&gt;exercise&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="6987" end="6995" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="At the time diagnoses had been made, a behavior was not considered a symptom of ADHD if occurring only in association with obesity treatment, for example, trouble adhering to diet or &lt;b&gt;exercise&lt;/b&gt; plans." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="3230" end="3238" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In the bariatric clinic at Behavioral Medicine Center for Treatment and Research (BMedCTR) in Portland, Oregon, among the patients who failed, a subset was observed to have unusual difficulty adhering to diet and &lt;b&gt;exercise&lt;/b&gt; plans, and as a result lost less fat mass than typically occurs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="6987" end="6995" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="At the time diagnoses had been made, a behavior was not considered a symptom of ADHD if occurring only in association with obesity treatment, for example, trouble adhering to diet or &lt;b&gt;exercise&lt;/b&gt; plans." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="3230" end="3238" sStart="null" offset="0" sid="null" wn="1" wnkey="physical_exercise%1:04:00::" text="In the bariatric clinic at Behavioral Medicine Center for Treatment and Research (BMedCTR) in Portland, Oregon, among the patients who failed, a subset was observed to have unusual difficulty adhering to diet and &lt;b&gt;exercise&lt;/b&gt; plans, and as a result lost less fat mass than typically occurs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="14783" end="14792" sStart="null" offset="42" sid="r8.1.different.j.0921" wn="1" wnkey="different%3:00:00::" text="The weight loss for NAD was again different from Obesity III patients who were AD or ADSx, but AD and ADSx were not significantly different (Fisher, NAD-AD: p &lt; 0.001, NAD-ADSx: p &lt; 0.01, AD-ADSx: p &lt; 0.657)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="14887" end="14896" sStart="null" offset="146" sid="r8.1.different.j.0031" wn="1" wnkey="different%3:00:00::" text="The weight loss for NAD was again different from Obesity III patients who were AD or ADSx, but AD and ADSx were not significantly different (Fisher, NAD-AD: p &lt; 0.001, NAD-ADSx: p &lt; 0.01, AD-ADSx: p &lt; 0.657)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="14887" end="14896" sStart="null" offset="146" sid="r8.1.different.j.0031" wn="1" wnkey="different%3:00:00::" text="The weight loss for NAD was again different from Obesity III patients who were AD or ADSx, but AD and ADSx were not significantly different (Fisher, NAD-AD: p &lt; 0.001, NAD-ADSx: p &lt; 0.01, AD-ADSx: p &lt; 0.657)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="14887" end="14896" sStart="null" offset="146" sid="r8.1.different.j.0031" wn="2" wnkey="different%5:00:00:other:00" text="The weight loss for NAD was again different from Obesity III patients who were AD or ADSx, but AD and ADSx were not significantly different (Fisher, NAD-AD: p &lt; 0.001, NAD-ADSx: p &lt; 0.01, AD-ADSx: p &lt; 0.657)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="14887" end="14896" sStart="null" offset="146" sid="r8.1.different.j.0031" wn="1" wnkey="different%3:00:00::" text="The weight loss for NAD was again different from Obesity III patients who were AD or ADSx, but AD and ADSx were not significantly different (Fisher, NAD-AD: p &lt; 0.001, NAD-ADSx: p &lt; 0.01, AD-ADSx: p &lt; 0.657)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="2388" end="2394" sStart="null" offset="225" sid="r10.common.j.0285" wn="1" wnkey="common%3:00:02::" text="However, one study [ 24 ] reported a potentially relevant correlation between symptoms of conduct disorder (but not depression) during adolescence and obesity in early adulthood, attributed to common mechanisms underlying &quot;impulsive aggression&quot; and dysregulation of body weight." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="850" end="856" sStart="null" offset="66" sid="r10.common.j.0744" wn="4" wnkey="common%5:00:00:familiar:02" text="Attention Deficit/Hyperactivity Disorder (ADHD) is also a common disorder, even if its prevalence is not precisely known." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="19651" end="19657" sStart="null" offset="62" sid="r10.common.j.0158" wn="4" wnkey="common%5:00:00:familiar:02" text="This syndrome is associated with obesity [ 34 ] , and common in ADHD [ 22 ] . The DRD4 gene has been associated with &quot;novelty seeking&quot; traits, said to be greater in substance abusers [ 30 ] , and individuals with both DRD2 and DRD4 genetic variations may be especially prone to multiple difficulties (e.g." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="31382" end="31388" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="The &lt;b&gt;chance&lt;/b&gt; that more knowledge could lead to reduction of suffering, disability and economic cost offers compelling reasons for further investigation of this subject." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="31382" end="31388" sStart="null" offset="0" sid="null" wn="5" wnkey="chance%1:26:01::" text="The &lt;b&gt;chance&lt;/b&gt; that more knowledge could lead to reduction of suffering, disability and economic cost offers compelling reasons for further investigation of this subject." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-244X-2-9.anc" start="31382" end="31388" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="The &lt;b&gt;chance&lt;/b&gt; that more knowledge could lead to reduction of suffering, disability and economic cost offers compelling reasons for further investigation of this subject." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="30946" end="30953" sStart="null" offset="262" sid="r11.benefit.n.0261" wn="2" wnkey="benefit%1:07:00::" text="Moreover, the impairment of ADHD is an intrinsic reason to diagnose and treat the condition, because even if comorbid obesity were not changed, normalizing brain function in ADHD sufferers more often than not provides substantial benefit and improved quality of life." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="18756" end="18762" sStart="null" offset="171" sid="r9.appear.v.0787" wn="4" wnkey="appear%2:39:01::" text="The reasons for a strong association between ADHD and obesity (particularly extreme obesity) are unknown, but there are a number of reported findings that appear to be relevant and certainly interesting." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-244X-2-9.anc" start="15845" end="15853" sStart="null" offset="162" sid="r9.appear.v.0624" wn="1" wnkey="appear%2:39:00::" text="The number of months in treatment was not significantly different among the patient groups (F = 2.03, df = 2,212, p = 0.13), though there appeared to be a trend toward alonger duration of treatment in AD." />
  </sentences>
</list>